Table 1 Details for GO terms and KEGG pathway enrichment in GSE64711

BP

GO:0042119

Neutrophil activation

41/269

498/18670

1.10e−19

3.90e−16

3.15e−16

BP

GO:0002446

Neutrophil mediated immunity

40/269

499/18670

8.35e−19

1.48e−15

1.19e−15

BP

GO:0043312

Neutrophil degranulation

39/269

485/18670

2.13e−18

2.34e−15

1.89e−15

CC

GO:0042581

Specific granule

21/276

160/19717

9.19e−15

3.20e−12

2.91e−12

CC

GO:0070820

Tertiary granule

20/276

164/19717

1.68e−13

2.93e−11

2.66e−11

CC

GO:0035580

Specific granule lumen

11/276

62/19717

8.95e−10

1.04e−07

9.46e−08

MF

GO:0004953

Icosanoid receptor activity

4/268

15/17697

6.15e−05

0.031

0.029

MF

GO:0030246

Carbohydrate binding

13/268

271/17697

2.63e−04

0.067

0.061

MF

GO:0016810

Hydrolase activity, acting on carbon–nitrogen (but not peptide) bonds

8/268

123/17697

5.72e−04

0.081

0.074

KEGG

hsa05140

Leishmaniasis

7/141

77/8076

3.70e−04

0.070

0.063

KEGG

hsa04066

HIF-1 signaling pathway

8/141

109/8076

6.10e−04

0.070

0.063

KEGG

hsa04621

NOD-like receptor signaling pathway

10/141

181/8076

0.001

0.073

0.066